SOURCE: Pipex Pharmaceuticals, Inc.

August 19, 2008 08:30 ET

Pipex Pharmaceuticals, Inc. to Present at the RedChip Small Cap Investor Conference in New York City

Live Webcast on Thursday, August 21st at 9:30 am EDT

ANN ARBOR, MI--(Marketwire - August 19, 2008) - Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, today announced that its Chief Executive Officer, Nicholas Stergis, will deliver a financial presentation to investors at the RedChip Emerging Markets Investor Conference on August 21st at the New York Marriott Marquis, located at 1535 Broadway, at 9:30am EDT. The investor conference will be held 8 a.m. to 5 p.m. and Mr. Stergis will be available throughout the day to meet with investors.

A live webcast of the presentation will be provided by Wall Street Webcasting, accessible via http://www.redchip.com.

About Pipex Pharmaceuticals, Inc.

Pipex Pharmaceuticals, Inc. is a specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of central nervous system and autoimmune diseases. Pipex's strategy is to exclusively in-license proprietary, clinical-stage drug candidates and to complete the further clinical testing, manufacturing and regulatory requirements and seek marketing authorizations. Pipex is focused on treating Dry Age-Related Macular Degeneration (AMD), multiple sclerosis (MS), and fibromyalgia. For further information, please visit www.pipexinc.com.

About RedChip Companies, Inc.

RedChip Companies is an international, small-cap research and financial public relations firm with offices in Orlando, Florida; Shanghai; and Paris, with affiliates in Atlanta, San Diego, and New York. RedChip has a national and international network of small-cap institutional and retail investors and has developed a comprehensive platform of products and services for small-cap companies, including: RedChip Research™, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Internet TV™, and RedChip Radio™.

Contact Information

  • Contact:

    Nicholas Stergis
    Chief Executive Officer
    (734) 332-7800

    Redington, Inc. (Investor Relations)
    Thomas Redington
    203-222-7399
    http://www.redingtoninc.com